MRV Engenharia e Participações (MRVE3) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
14 Aug, 2026Executive summary
Achieved record gross margin of 31.2% in real estate development, the highest in seven years, with new sales margins approaching 35%.
Strong cash generation reached R$470 million in 1H26, driven by asset sales and improved operational results in Brazil.
Net pre-sales in real estate development hit an all-time record of R$10.3 billion LTM.
Major asset sales and deleveraging initiatives were executed, including US$401 million in Resia asset sales and a memorandum to sell Luggo assets for R$166 million.
Continued focus on simplification, deleveraging, and capital structure strengthening through asset recycling and exit from US operations.
Financial highlights
Net operating revenue for H1 2026 reached R$5.78 billion, up 15.7% year-over-year; LTM net revenue for real estate development was R$10.8 billion.
Adjusted net income for H1 2026 was R$288 million, up 107.4% year-over-year; Q2 2026 adjusted net income was R$155 million, up 28.2% year-over-year.
Gross margin in real estate development was 31.2% in Q2 2026, with gross profit for H1 2026 at R$1.72 billion.
Net loss for H1 2026 was R$722 million, improved from a R$1.2 billion loss in H1 2025.
EBITDA LTM for real estate development reached R$2.1 billion, up 50.6% year-over-year.
Outlook and guidance
Management expects further gross margin expansion as higher-margin new sales flow through.
Cash generation and profitability are projected to accelerate, with further deleveraging anticipated from ongoing asset sales and transfers.
Continued discipline in land acquisition and capital allocation to sustain profitability.
Positive outlook for sales in H2 2026 and 2027, with no anticipated negative impact from elections.
Latest events from MRV Engenharia e Participações
- Net revenue rose 18% to R$2.78 billion, with gross margin up and adjusted net profit at R$133 million.MRVE3
Q1 2026 - Margin expansion, asset-light growth, and operational excellence drive improved results.MRVE3
Investor Day 2026 - Record revenue and EBITDA growth, but year closed with net loss and increased leverage.MRVE3
Q4 2025 - Strong revenue and margin growth, with deleveraging and regulatory tailwinds despite US impairments.MRVE3
Q3 2025 - Strong revenue and margin growth in Brazil offset by US asset impairments and net loss.MRVE3
Q2 2025 - Asset-light strategy and divestments drive deleveraging and focus on high-return projects.MRVE3
Investor Update - Record pre-sales and cash generation support a strong outlook despite US losses.MRVE3
Q3 2024 - Revenue and launches surged, but cash flow and US impairments weighed on results.MRVE3
Q1 2025 - Record sales, margin expansion, and cash generation drive strong 2024 results and 2025 outlook.MRVE3
Q4 2024